Saquinavir: Difference between revisions
imported>David E. Volk No edit summary |
imported>Caesar Schinas m (Robot: Automated text replacement (-* {{CZMed +{{CZMed)) |
||
| (3 intermediate revisions by one other user not shown) | |||
| Line 4: | Line 4: | ||
{{Chem infobox | {{Chem infobox | ||
|align=right | |align=right | ||
|image=[[Image:Saquinavir structure.jpg| | |image=[[Image:Saquinavir structure.jpg|center|thumb|250px]] | ||
|width=250px | |width=250px | ||
|molname=saquinavir | |molname=saquinavir | ||
|synonyms= SVQ | |synonyms= SVQ | ||
|molformula= C<sub>38</sub>H<sub>5</sub> | |molformula= C<sub>38</sub>H<sub>5</sub>N<sub>6</sub>O<sub>5</sub> | ||
|molmass= 670.8408 | |molmass= 670.8408 | ||
|uses= HIV | |uses= HIV | ||
| Line 18: | Line 18: | ||
'''Saquinavir''', abbreviated '''SQV''' and sold under the trade names '''Fortovase®''', '''Invirase®''' and '''ROC®''', is a [[protease inhibitor]] used to treate [[HIV]]/[[AIDS]]. It is effective againsts HIV-1 and HIV-2. Saquinavir binds to the protease active site and inhibits its activity, thus preventing cleavage of the viral polyproteins resulting in immature non-infectious viral particles. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs and due to their short half-life, often must be taken about every four hours. | '''Saquinavir''', abbreviated '''SQV''' and sold under the trade names '''Fortovase®''', '''Invirase®''' and '''ROC®''', is a [[protease inhibitor]] used to treate [[HIV]]/[[AIDS]]. It is effective againsts HIV-1 and HIV-2. Saquinavir binds to the protease active site and inhibits its activity, thus preventing cleavage of the viral polyproteins resulting in immature non-infectious viral particles. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs and due to their short half-life, often must be taken about every four hours. | ||
== Chemistry == | == Chemistry == | ||
Its IUPAC chemical name is (2S)-N-[(2S,3R)-4-[(3S)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide and its chemical formula is C<sub>38</sub>H<sub>5</sub> | Its IUPAC chemical name is (2S)-N-[(2S,3R)-4-[(3S)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide and its chemical formula is C<sub>38</sub>H<sub>5</sub>N<sub>6</sub>O<sub>5</sub>. | ||
== External links == | == External links == | ||
{{CZMed}} | |||
Latest revision as of 01:27, 4 June 2009
|
| |||||||
| saquinavir | |||||||
| |||||||
| Uses: | HIV | ||||||
| Properties: | protease inhibitor | ||||||
| Hazards: | see drug interactions | ||||||
| |||||||
Saquinavir, abbreviated SQV and sold under the trade names Fortovase®, Invirase® and ROC®, is a protease inhibitor used to treate HIV/AIDS. It is effective againsts HIV-1 and HIV-2. Saquinavir binds to the protease active site and inhibits its activity, thus preventing cleavage of the viral polyproteins resulting in immature non-infectious viral particles. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs and due to their short half-life, often must be taken about every four hours.
Chemistry
Its IUPAC chemical name is (2S)-N-[(2S,3R)-4-[(3S)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide and its chemical formula is C38H5N6O5.
External links
The most up-to-date information about Saquinavir and other drugs can be found at the following sites.
- Saquinavir - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Saquinavir - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Saquinavir - Detailed information from DrugBank.